Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
13 February 2012

IN THIS ISSUE
Pfizer recall
EU pharmacovigilance
New digital magazine
GSK finances


Pfizer contraceptive pill packaging error leads to recall
Following a packaging error affecting birth-control pills, Pfizer has issued a one-million pack recall and warned women in the US who have been taking the medication during the last several months to "…consult with your physician and begin using a nonhormonal barrier method immediately." More...
 
EMA to implement pharmacovigilance
The European Medicines Agency (EMA) has published an implementation plan for Europe's new pharmacovigilance legislation, which comes into force in July with the aim of improving the safety and risk–benefit monitoring of drugs. More...
 
New PTE Digital tablet edition launched
Pharmaceutical Technology Europe is now available in a new digital format with fresh content. Download Nxtbook Nxtstand at the iTunes App Store, find us in the catalog, and start connecting with PTE in a brand new way. Featuring news roundups, social media feeds and bite-sized versions of in-depth articles, you can now access PharmTech.com content through an eye-catching, easily accessible portal. For those without an iPad, access the new format here. More...
 
GlaxoSmithKline tracks R&D performance
GlaxoSmithKline has released its fourth quarter and full year 2011 earnings report, and calculated the return on R&D to be 12%, up from 11% in 2010, and closing in on the company's goal of a 14% return. More...
 
FDA testifies for user-fees reauthorisation
FDA Commissioner Margaret A. Hamburg has testified to support the fifth authorization of the Prescription Drug User Fee Act (PDUFA), also known as PDUFA V. More...
 
Follow us on Twitter
We tweet regularly about the latest news, trends and rumours hitting the web about the bio/pharma industry. Follow us to make sure you don't miss out! More...
Key Topics:

Latest blog posts
Pfizer's birth control recall
Is the US facing a pharmaceutical manufacturing gap?
FDA gives biosimilars update
More blog posts

Latest articles
Pointed debate: expert views on injectables
Understanding gamma sterilisation
Decoding the hype and fear of nanomedicines
More articles

Upcoming events
Encouraging Development of Therapeutics for Neglected Diseases (12–13 March | USA)
BIO-Europe Spring (19–21 March | The Netherlands)
8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (19–22 March | Turkey)
More events

Products/Service Profiles
Jones Lang LaSalle

Specialist chemicals plant for sale in Church Village, South Wales.  Clariant Chemicals to dispose of Parabens & Polymer production facility, Jones Lang LaSalle’s Cardiff office instructed to market.
Read more

 
Survey
What is the most important change that has influenced chemical API manufacturing during the past 10 years?
Advancements in chemocatalysis (for use in asymmetric hydrogenation and other asymmetric syntheses) 13%
 
Adoption of biocatalysis in organic chemical synthesis 11%
     
Development of microreactors for continuous manufacturing 16%
     
Application of quality-by-design principles in process development and manufacturing 60%

This week we would like to know...

Which is your preferred social media tool for professional use?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.